Skip to main content
TipRanks
Go Ultimate75% OFF

Provectus Pharmaceuticals (PVCT) Ratios

81 Followers

Provectus Pharmaceuticals Ratios

PVCT's free cash flow for Q3 2026 was $-859.60K. For the 2026 fiscal year, PVCT's free cash flow was decreased by $-5.00 and operating cash flow was $-859.60K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.080.140.150.230.45
Quick Ratio0.080.140.150.230.45
Cash Ratio0.040.040.010.000.09
Solvency Ratio-0.78-0.68-0.34-0.42-0.71
Operating Cash Flow Ratio-0.48-0.47-0.29-0.37-0.13
Short-Term Operating Cash Flow Coverage-1.18-1.04-0.87-1.44-0.58
Net Current Asset Value$ -6.43M$ -6.00M$ -7.68M$ -6.37M$ -4.26M
Leverage Ratios
Debt-to-Assets Ratio4.273.162.091.090.50
Debt-to-Equity Ratio-0.47-0.53-0.40-0.36-0.42
Debt-to-Capital Ratio-0.90-1.15-0.66-0.56-0.71
Long-Term Debt-to-Capital Ratio-0.000.000.000.000.00
Financial Leverage Ratio-0.11-0.17-0.19-0.33-0.84
Debt Service Coverage Ratio-1.59-1.33-0.91-1.48-1.71
Interest Coverage Ratio-23.03-16.54-13.42-20.94-4.86
Debt to Market Cap0.120.060.070.050.08
Interest Debt Per Share0.010.010.010.010.01
Net Debt to EBITDA-0.56-0.64-1.02-0.66-0.23
Profitability Margins
Gross Profit Margin99.45%98.84%-204.77%93.55%0.00%
EBIT Margin-1441.28%-734.36%-520.16%-346.60%0.00%
EBITDA Margin-1440.73%-733.22%-518.55%-340.13%0.00%
Operating Profit Margin-1441.28%-640.81%-520.16%-346.60%0.00%
Pretax Profit Margin-1637.90%-773.13%-558.89%-359.44%0.00%
Net Profit Margin-1615.81%-766.92%-556.20%-359.34%0.00%
Continuous Operations Profit Margin-1637.90%-771.62%-556.20%-359.44%0.00%
Net Income Per EBT98.65%99.20%99.52%99.97%100.00%
EBT Per EBIT113.64%120.65%107.45%103.70%118.58%
Return on Assets (ROA)-778.61%-470.36%-214.10%-174.45%-157.68%
Return on Equity (ROE)86.17%79.42%40.85%57.06%132.31%
Return on Capital Employed (ROCE)78.13%66.25%38.33%55.69%111.58%
Return on Invested Capital (ROIC)145.74%141.75%63.20%85.71%194.86%
Return on Tangible Assets-778.61%-470.36%-214.10%-174.45%-157.68%
Earnings Yield-23.12%-9.39%-7.70%-7.82%-24.67%
Efficiency Ratios
Receivables Turnover0.000.001171.662510.260.00
Payables Turnover0.000.011.010.030.07
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover2.6520.936.647.160.00
Asset Turnover0.480.610.380.490.00
Working Capital Turnover Ratio-0.05-0.09-0.08-0.190.00
Cash Conversion Cycle-140322.22-56440.90-359.72-11985.24-4992.64
Days of Sales Outstanding0.000.000.310.150.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding140322.2256440.90360.0411985.394992.64
Operating Cycle0.000.000.310.150.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.01-0.01-0.01-0.01-0.00
Free Cash Flow Per Share-0.01-0.01-0.01-0.01-0.00
Dividend Paid and CapEx Coverage Ratio0.000.00-1285989.000.000.00
Capital Expenditure Coverage Ratio0.000.00-1285989.000.000.00
Operating Cash Flow Coverage Ratio-1.12-1.03-0.85-1.36-0.58
Operating Cash Flow to Sales Ratio-9.90-5.32-4.61-3.080.00
Free Cash Flow Yield-14.16%-6.51%-6.39%-6.70%-4.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-4.33-10.63-12.98-12.78-4.05
Price-to-Sales (P/S) Ratio69.9081.7072.2145.930.00
Price-to-Book (P/B) Ratio-3.73-8.46-5.30-7.29-5.36
Price-to-Free Cash Flow (P/FCF) Ratio-7.06-15.35-15.66-14.94-22.16
Price-to-Operating Cash Flow Ratio-7.06-15.35-15.66-14.94-22.16
Price-to-Earnings Growth (PEG) Ratio-0.31-0.201.000.270.20
Enterprise Value Multiple-5.41-11.78-14.95-14.16-5.09
Enterprise Value26.22M53.30M43.22M47.64M23.51M
EV to EBITDA-5.41-11.78-14.95-14.16-5.09
EV to Sales78.0186.3677.5048.160.00
EV to Free Cash Flow-7.88-16.23-16.81-15.66-23.20
EV to Operating Cash Flow-7.88-16.23-16.81-15.66-23.20
Tangible Book Value Per Share-0.01-0.01-0.02-0.01-0.01
Shareholders’ Equity Per Share-0.01-0.01-0.02-0.01-0.01
Tax and Other Ratios
Effective Tax Rate0.000.000.010.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.01-0.01-0.01-0.01-0.01
Tax Burden0.990.991.001.001.00
Interest Burden1.141.051.071.041.19
Research & Development to Revenue5.643.233.142.420.00
SG&A to Revenue11.115.102.342.050.00
Stock-Based Compensation to Revenue3.682.080.010.000.00
Income Quality0.610.690.830.860.18

Currency in USD